Around the world, in more than 100 sales, manufacturing and regional offices, Avient and its employees are committed to being a positive presence in the communities in which we work and live. Product Stewardship & Global Chemical Management + Product Excellence Enterprise Risk Management

These challenges may include long turnaround times, complicated inventory management, or noncompetitive pricing. An enhanced focus on inventory management with daily counts and an organized environment is key, and using effective software to track your inventory is highly recommended. Accurate sales forecasting can also ease some of the timing issues, better preparing you for possible delays or lengthy order times.  

These are supported by laboratory facilities as well as technical and commercial teams that are thoroughly trained in risk assessment and change management, according to global MEVOPUR standards. The goal behind the MEVOPUR concept is to help customers navigate more easily through a changing regulatory landscape,” explains Volker Dickfeld, global marketing manager Healthcare. Media contact Michelle Maniscalco Senior Manager, Marketing Communications Avient Corporation michelle.maniscalco@avient.com

This portfolio combines expertise in polymer formulation with controlled manufacturing conditions and robust change control management beyond the Chemical Abstracts Service (CAS) identification number. Marketing Manager Healthcare Global for Color & Additives in Avient. The materials are produced under a third-party certified ISO 13485:2016 quality management system and backed by comprehensive change control of raw materials, formulation, and manufacturing standards to enable consistent batch-to-batch quality.”

Select the correct colorants to manage warpage and dimensional stability Consider additives that help manage recrystallization and cooling in the tooling  Use additive and process technologies to manage odors

They are based on management’s expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements. Senior management believes these measures are useful to investors because they allow for comparison to Avient's performance in prior periods without the effect of items that, by their nature, tend to obscure Avient's operating results due to the potential variability across periods based on timing, frequency and magnitude. Three Months Ended December 31, Year Ended December 31, Reconciliation to Consolidated Statements of Income 2023 2022 2023 2022 Sales $ 719.0 $ 790.4 $ 3,142.8 $ 3,396.9 Gross margin - GAAP 208.9 172.0 892.5 882.7 Special items in gross margin (Attachment 3) 17.6 45.5 80.0 81.1 Adjusted gross margin $ 226.5 $ 217.5 $ 972.5 $ 963.8 Adjusted gross margin as a percent of sales 31.5 % 27.5 % 30.9 % 28.4 % Operating income - GAAP 43.1 0.4 196.8 243.3 Special items in operating income (Attachment 3) 26.1 59.9 116.0 108.7 Adjusted operating income $ 69.2 $ 60.3 $ 312.8 $ 352.0 Adjusted operating income as a percent of sales 9.6 % 7.6 % 10.0 % 10.4 % The following pro forma adjustments are referenced by management to provide comparable business performance by incorporating the APM business in periods prior to the acquisition date (September 1, 2022).

Adjusted EPS of $0.52 exceeded the $0.48 projection included in the Company’s performance update provided in December and was driven by better-than-expected sales in the Color, Additives and Inks segment. Management believes this provides comparability of the performance of the combined businesses. They are based on management's expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements.

Management believes this provides better comparability of the performance of the combined businesses. They are based on management's expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements. Senior management believes these measures are useful to investors because they allow for comparison to Avient's performance in prior periods without the effect of items that, by their nature, tend to obscure Avient's operating results due to the potential variability across periods based on timing, frequency and magnitude.

Acquisitions increased sales by 4.0%, while foreign exchange negatively impacted sales 5.6%. Avient records reductions to sales for customer incentives, primarily comprised of rebates, at the time of the initial sale. Rebates are estimated based on sales terms, historical experience along with annual sales projections.

Given these factors we anticipate full-year sales of $3.45 billion, adjusted EBITDA of $530 million and adjusted EPS of $2.40.” Management believes this provides better comparability of the performance of the combined businesses. They are based on management’s expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements.